American Association for Cancer Research

SHERPA: Unknown

People

  1. Rosen
    Rosen
  2. Hudis
    Hudis
  3. Norton
    Norton
  4. Solit
    Solit
  5. Chandarlapaty
    Chandarlapaty
  6. Robson
    Robson
  7. Modi
    Modi
  8. Traina
    Traina
  9. Dang
    Dang
  10. Jhaveri
    Jhaveri

Groups

  1. Breast Medicine Service (611)
  2. Department of Medicine (611)
  3. Solid Tumor Oncology Division (611)
  4. GSK Faculty (310)
  5. Survivorship Research (290)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (199)
  7. Human Oncology and Pathogenesis Program (182)
  8. Sloan Kettering Institute Faculty (174)
  9. Molecular Pharmacology and Chemistry Program Faculty (153)
  10. Population Sciences Research Program (137)
Search Within
  1. "Breast Medicine Service"
Formats
  1. Meeting Abstract (451)
  2. Journal Article (158)
  3. Miscellaneous (2)
Groups
  1. Breast Medicine Service (611)
  2. Department of Medicine (611)
  3. Solid Tumor Oncology Division (611)
  4. GSK Faculty (310)
  5. Survivorship Research (290)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (199)

More Groups

People
  1. Neal Rosen (142)
  2. Clifford Hudis (141)
  3. Larry Norton (110)
  4. David Solit (87)
  5. Sarat Chandarlapaty (76)
  6. Mark Robson (67)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (19)
  5. 2021 (46)
  6. 2020 (67)

More Years

Publications
  1. Cancer Research (481)
  2. Clinical Cancer Research (130)

Results (611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying triple-negative breast cancer patients at high risk of worse prognosis using molecular features derived from histology images
    Meeting Abstract

    Oh, J. H.; Pareja, F.; Elkin, R.; Norton, L.; Deasy, J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • A genomics-driven artificial intelligence–based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms
    Journal Article

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A. M.; Brown, D. N.; Banerjee, M.; Selenica, P.; Bernhard, J. H.; Derakhshan, F.; da Silva, E. M.; more...
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase II DORA study of olaparib with or without durvalumab as a chemotherapy-free maintenance strategy in platinum-pretreated advanced triple-negative breast cancer
    Journal Article

    Tan, T. J.; Sammons, S.; Im, Y. H.; She, L.; Mundy, K.; Bigelow, R.; Traina, T. A.; Anders, C.; Yeong, J.; Renzulli, E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase Ia/b study of giredestrant ± palbociclib and ± luteinizing hormone-releasing hormone agonists in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; Bellet, M.; Turner, N. C.; Loi, S.; Bardia, A.; Boni, V.; Sohn, J.; Neilan, T. G.; Villanueva-Vázquez, R.; Kabos, P.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor–positive breast cancer
    Journal Article

    Chandarlapaty, S.; Dickler, M. N.; Perez Fidalgo, J. A.; Villanueva-Vázquez, R.; Giltnane, J.; Gates, M.; Chang, C. W.; Cheeti, S.; Fredrickson, J.; Wang, X.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Cytochrome P450 oxidoreductase (POR) associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
    Journal Article

    Shen, F.; Jiang, G.; Philips, S.; Gardner, L.; Xue, G.; Cantor, E.; Ly, R. C.; Osei, W.; Wu, X.; Dang, C.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: